<DOC>
	<DOCNO>NCT01810679</DOCNO>
	<brief_summary>To demonstrate safety effectiveness Perceval S heart valve use replace diseased dysfunctional aortic valve aortic valve prosthesis .</brief_summary>
	<brief_title>Perceval S Aortic Heart Valve Study- North America</brief_title>
	<detailed_description>This investigation prospective , non-randomized , multi-center trial PERCEVAL valve implant patient require aortic valve replacement . The study conduct maximum 25 center United States . Patients evaluate following time interval : preoperative , implant , early postoperative period , late postoperative period ( 3 6 month postoperatively ) , 1 year ( 11 13 month postoperatively ) , annually study completion . The duration study anticipate 5 year .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>Inclusion criterion : 1 . Subjects age &gt; = 18 year . 2 . Subjects aortic valve stenosis stenoinsufficiency . 3 . The subject willing sign inform consent . 4 . The subject preoperative evaluation indicate need native prosthetic aortic valve replacement . 5 . The subject locate geographic location enable subject return study site followup examination ( i.e . geographically stable ) . 6 . Subject available investigator ( ) postoperative followup beyond one year . Exclusion criterion : 1 . The subject preexisting valve prosthesis annuloplasty ring mitral , pulmonic tricuspid position . 2 . The subject require double multiple valve replacement repair mitral , tricuspid , pulmonic valve . 3 . The subject previously implant PERCEVAL valve require replacement . 4 . Subjects require simultaneous cardiac procedure , apart septal myectomy and/or coronary bypass . 5 . The subject active endocarditis . 6 . Subjects active myocarditis 7 . The subject participate concomitant research study investigational product . 8 . Subjects aneurysmal dilation dissection ascend aortic wall . 9 . The subject minor , drug abuser , alcohol abuser , prison inmate , institutionalize , unable give inform consent . 10 . The subject major progressive noncardiac disease , investigator 's experience , result life expectancy le 1 year , implant device produce unacceptable increase risk patient . 11 . Subjects know hypersensitivity nickel alloy . 12 . The subject undergoing renal dialysis chronic renal failure hyperparathyroidism . 13 . The subject acute preoperative neurological deficit , myocardial infarction , cardiac event return baseline stabilize â‰¥30 day prior plan valve implant surgery . 14 . Subject know noncompliant unlikely complete study . 15 . Subjects aortic root enlargement , ratio diameter sinotubular junction annulus diameter , assess TTE , &gt; 1.3 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>aortic valve replacement</keyword>
	<keyword>aortic stenosis</keyword>
	<keyword>aortic steno-insufficiency</keyword>
	<keyword>Perceval</keyword>
	<keyword>Sutureless aortic heart valve</keyword>
</DOC>